<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-037873</identifier>
<setSpec>0303-8874</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prognosis value of the immunohistochemical expresion of the bcl-2 in the larynx epidermoid cancer</dc:title>
<dc:description xml:lang="en">In this paper we carried out an immunohistochemical study of protein p21WAF1 (EA 10) expression in a series of 195 patients with laryngeal carcinoma that were diagnosticated, treated and followed at the Department of Otolaryngology at «Virgen de la Salud» Hospital (Toledo, Spain). In the cases with lymph node metastasis; we also studied p21WAF1 expression at this level. Furthermore we have analysed the value of protein p21WAF1 expression as a prognostic factor (tumor recurrence, deads due to cancer and survival (and we evaluate the relationship between p21WAF1 expression and other clinic and pathologic parameters. Keywords: p21WAFl Protein. Larynx cancerIn this paper we carried out an immunohistochemical study of bcl-2 protein expression in a series of 195 patients with laryngeal carcinoma that were diagnosticated, treated and followed at the Department of Otolaryngology at «Virgen de la Salud» Hospital (Toledo. Spain). In the cases with lymphonode metastasis we also analysed bcl-2 protein expression at this level. Furthermore we have studied the value of bcl-2 protein expression as a prognostic factor (tumor recurrence, deads due to cancer and survival) and we analysed the relationship between bcl-2 protein expression and other clinic and pathologic parametersIn this paper we carried out an immunohistochemical study of protein Rb (G3-245) expression in a series of 195 patients with laryngeal carcinoma that were diagnosticated, treated and followed at the Department of Otolaryngology at «Virgen de la Salud» Hospital (Toledo, Spain) for a time of 5 years. In the cases with lymph node metastasis we also studied Rb expression at this level. Furthermore we have analysed the value of Rb expression as a prognostic factor (tumor recurrence, deads due to cancer and survival) and we evaluate the relationship between Rb expression and other clinic and pathologic parameters</dc:description>
<dc:creator>Sáez del Castillo, A. I</dc:creator>
<dc:creator>García Lozano, M. C</dc:creator>
<dc:creator>Piris Pinilla, M. A</dc:creator>
<dc:creator>Caro García, M</dc:creator>
<dc:creator>Galán Morales, J. T</dc:creator>
<dc:creator>Orradre Romero, J. L</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">En este trabajo hemos estudiado la expresión inmunohistoquímica de la proteína bcl-2 en 195 pacientes con cáncer de laringe que fueron diagnosticados, tratados y seguidos durante 5 años en el servicio ORL del Hospital &#147;Virgen de la Salud&#148; (Toledo). En los casos que presentaron metástasis ganglionares analizamos también la expresión de bcl-2 a dicho nivel. Además se ha estudiado el valor pronóstico de la expresión de bcl-2 en este tipo de tumores (desarrollo de recidivas, mortalidad por cáncer de laringe y supervivencia) y analizamod la posible relación de dicha expresión con otros parámetros clínicopatológicos</dc:description>
<dc:source>An Otorrinolaringol Ibero Am;32(1): 29-46, ene.-feb. 2005. ilus, tab</dc:source>
<dc:identifier>ibc-037873</dc:identifier>
<dc:title xml:lang="es">Valor pronóstico de la expresión inmunohistoquímica de la proteína bcl-2 en carcinoma de laringe</dc:title>
<dc:subject>^d29089^s22038</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d33061^s22038</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d33061^s22044</dc:subject>
<dc:subject>^d28150^s22038</dc:subject>
<dc:subject>^d29089^s22044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d920^s22038</dc:subject>
<dc:subject>^d28150^s22044</dc:subject>
<dc:subject>^d22921</dc:subject>
<dc:subject>^d2337^s22038</dc:subject>
<dc:subject>^d2337^s22044</dc:subject>
<dc:subject>^d9560</dc:subject>
<dc:type>article</dc:type>
<dc:date>200502</dc:date>
</metadata>
</record>
</ibecs-document>
